BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 1432006)

  • 1. Meta-analysis adjusting for compliance: the example of screening for breast cancer.
    Glasziou PP
    J Clin Epidemiol; 1992 Nov; 45(11):1251-6. PubMed ID: 1432006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased benefit from shorter screening mammography intervals for women ages 40-49 years.
    Feig SA
    Cancer; 1997 Dec; 80(11):2035-9. PubMed ID: 9392324
    [No Abstract]   [Full Text] [Related]  

  • 3. The Canadian National Breast Screening Study-1: breast cancer mortality after 11 to 16 years of follow-up. A randomized screening trial of mammography in women age 40 to 49 years.
    Miller AB; To T; Baines CJ; Wall C
    Ann Intern Med; 2002 Sep; 137(5 Part 1):305-12. PubMed ID: 12204013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammography: reviewing the evidence. Epidemiology aspect.
    Miller AB
    Can Fam Physician; 1993 Jan; 39():85-90. PubMed ID: 8435565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Summaries for patients. Mammograms in women age 40 to 49: results of the Canadian Breast Cancer Screening study.
    Ann Intern Med; 2002 Sep; 137(5 Part 1):I28. PubMed ID: 12204045
    [No Abstract]   [Full Text] [Related]  

  • 6. Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years.
    Miller AB; Baines CJ; To T; Wall C
    CMAJ; 1992 Nov; 147(10):1477-88. PubMed ID: 1423088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years.
    Miller AB; Baines CJ; To T; Wall C
    CMAJ; 1992 Nov; 147(10):1459-76. PubMed ID: 1423087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoting regular mammography screening II. Results from a randomized controlled trial in US women veterans.
    Vernon SW; del Junco DJ; Tiro JA; Coan SP; Perz CA; Bastian LA; Rakowski W; Chan W; Lairson DR; McQueen A; Fernandez ME; Warrick C; Halder A; DiClemente C
    J Natl Cancer Inst; 2008 Mar; 100(5):347-58. PubMed ID: 18314474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency and predictive value of a mammographic recommendation for short-interval follow-up.
    Yasmeen S; Romano PS; Pettinger M; Chlebowski RT; Robbins JA; Lane DS; Hendrix SL
    J Natl Cancer Inst; 2003 Mar; 95(6):429-36. PubMed ID: 12644536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force.
    Humphrey LL; Helfand M; Chan BK; Woolf SH
    Ann Intern Med; 2002 Sep; 137(5 Part 1):347-60. PubMed ID: 12204020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis of breast cancer mortality benefit and overdiagnosis adjusted for adherence: improving information on the effects of attending screening mammography.
    Jacklyn G; Glasziou P; Macaskill P; Barratt A
    Br J Cancer; 2016 May; 114(11):1269-76. PubMed ID: 27124337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compliance with screening mammography and breast sonography of young Asian women.
    Tsai HW; Twu NF; Ko CC; Yen MS; Yang MJ; Chao KC; Wen L; Chen CY; Chou YH; Chen YJ
    Eur J Obstet Gynecol Reprod Biol; 2011 Jul; 157(1):89-93. PubMed ID: 21439713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mammographic screening of women aged 40 to 49 years. Is it justified?
    Feig SA
    Obstet Gynecol Clin North Am; 1994 Dec; 21(4):587-606. PubMed ID: 7731636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A different view on what is known about breast screening and the Canadian National Breast Screening Study.
    Baines CJ
    Cancer; 1994 Aug; 74(4):1207-11. PubMed ID: 8055439
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of screening mammography. A meta-analysis.
    Kerlikowske K; Grady D; Rubin SM; Sandrock C; Ernster VL
    JAMA; 1995 Jan; 273(2):149-54. PubMed ID: 7799496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefit of screening mammography in women aged 40-49: a new meta-analysis of randomized controlled trials.
    Hendrick RE; Smith RA; Rutledge JH; Smart CR
    J Natl Cancer Inst Monogr; 1997; (22):87-92. PubMed ID: 9709282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mammographic surveillance of breast cancer patient relatives; implementation of guidelines formulated by the Netherlands College of General Practitioners].
    Duijm LE; Zaat JO; Guit GL
    Ned Tijdschr Geneeskd; 1998 Apr; 142(14):778-81. PubMed ID: 9646610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammographic screening trials for women aged under 50. A quality assessment and meta-analysis.
    Glasziou PP; Woodward AJ; Mahon CM
    Med J Aust; 1995 Jun; 162(12):625-9. PubMed ID: 7603372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Canadian National Breast Screening Study: a perspective on criticisms.
    Baines CJ
    Ann Intern Med; 1994 Feb; 120(4):326-34. PubMed ID: 8291826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical breast examination: preliminary results from a cluster randomized controlled trial in India.
    Sankaranarayanan R; Ramadas K; Thara S; Muwonge R; Prabhakar J; Augustine P; Venugopal M; Anju G; Mathew BS
    J Natl Cancer Inst; 2011 Oct; 103(19):1476-80. PubMed ID: 21862730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.